• Something wrong with this record ?

Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

A. Wierzbowska, E. Wawrzyniak, A. Pluta, T. Robak, GJ. Mazur, A. Dmoszynska, J. Cermak, A. Oriol, D. Lysak, C. Arthur, M. Doyle, L. Xiu, F. Ravandi, HM. Kantarjian,

. 2018 ; 93 (5) : E125-E127. [pub] 20180224

Language English Country United States

Document type Clinical Trial, Phase III, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19028586

Grant support
P30 CA016672 NCI NIH HHS - United States

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028586
003      
CZ-PrNML
005      
20190816110427.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ajh.25062 $2 doi
035    __
$a (PubMed)29417613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wierzbowska, Agnieszka $u Department of Hematology, Medical University of Lodz, Lodz, Poland.
245    10
$a Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial / $c A. Wierzbowska, E. Wawrzyniak, A. Pluta, T. Robak, GJ. Mazur, A. Dmoszynska, J. Cermak, A. Oriol, D. Lysak, C. Arthur, M. Doyle, L. Xiu, F. Ravandi, HM. Kantarjian,
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a decitabin $x farmakologie $x terapeutické užití $7 D000077209
650    _2
$a lidé $7 D006801
650    12
$a karyotypizace $7 D007621
650    _2
$a akutní myeloidní leukemie $x farmakoterapie $x genetika $x mortalita $7 D015470
650    12
$a monozomie $7 D009006
650    12
$a doba přežití bez progrese choroby $7 D000077982
650    _2
$a analýza přežití $7 D016019
655    _2
$a klinické zkoušky, fáze III $7 D017428
655    _2
$a dopisy $7 D016422
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Wawrzyniak, Ewa $u Department of Hematology, Medical University of Lodz, Lodz, Poland.
700    1_
$a Pluta, Agnieszka $u Department of Hematology, Medical University of Lodz, Lodz, Poland.
700    1_
$a Robak, Tadeusz $u Department of Hematology, Medical University of Lodz, Lodz, Poland.
700    1_
$a Mazur, Grzegorz J $u Department of Internal Disease, Wroclaw Medical University, Wroclaw, Poland.
700    1_
$a Dmoszynska, Anna $u Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
700    1_
$a Cermak, Jaroslav $u Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic.
700    1_
$a Oriol, Albert $u Institut Català d'Oncologia, Institut Josep Carreras,Hospital Germans Trias i Pujol, Barcelona, Spain.
700    1_
$a Lysak, Daniel $u Department of Hematology and Oncology, Medical School and Teaching Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic.
700    1_
$a Arthur, Chris $u Haematology Department, Royal North Shore Hospital, St Leonards, New South Whales, Australia.
700    1_
$a Doyle, Margaret $u EMEA Medical Affairs, Janssen Sciences, Ireland.
700    1_
$a Xiu, Liang $u Janssen Research & Development LLC, Raritan, New Jersey.
700    1_
$a Ravandi, Farhad $u Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
700    1_
$a Kantarjian, Hagop M $u Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
773    0_
$w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 93, č. 5 (2018), s. E125-E127
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29417613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190816110656 $b ABA008
999    __
$a ok $b bmc $g 1433735 $s 1067046
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 93 $c 5 $d E125-E127 $e 20180224 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
GRA    __
$a P30 CA016672 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Archiving options